Results 191 to 200 of about 94,276 (301)

Early‐stage health technology assessment of a curative gene therapy for multiple sclerosis

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Multiple sclerosis (MS) is associated with significant early morbidity, reduced life expectancy and substantial healthcare and societal costs. The primary objective of this study is to assess the early cost‐effectiveness potential of a novel gene therapy, IMMUTOL, for MS compared with current high‐efficacy treatment sequences.
Attila Imre, Balázs Nagy, Rok Hren
wiley   +1 more source

Global Aid Cuts and Local Health Consequences in Nakivale Refugee Settlement, Uganda.

open access: yesJAMA Netw Open
Lee H   +4 more
europepmc   +1 more source

Cost‐utility analysis of nusinersen–risdiplam switch in patients with spinal muscular atrophy in Croatia: A discrete event simulation model

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Introduction In recent years, the treatment of spinal muscular atrophy (SMA), a rare disease, has significantly progressed, improving patients' survival and overall quality of life. However, current SMA treatments are expensive, and some (nusinersen) are very inconvenient for patients.
Andrej Belančić   +4 more
wiley   +1 more source

Surgical training in the age of climate crises: preparing green future surgeons. [PDF]

open access: yesAnn Med Surg (Lond)
Akhter J   +4 more
europepmc   +1 more source

Long-run neutrality of money supply for food prices in Germany with policy effects

open access: yes
Using a modified Fisher-Seater model with consideration of policy impacts, this paper attempts to tests the long-run neutrality of money supply on food prices in Germany after the launching of the Eurozone.
Yu, Xiaohua, Meyer, Stefan
core  

How the HTAR will contribute to a value‐based decision‐making for medicinal products across the EU

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
The European Union Health Technology Regulation 2021/2282 (HTAR) introduces joint assessment of health technologies (including medicinal products and medical devices) across EU Member States. It was signed into law in 2021 and came into full force in January 2025.
Roisin Adams, Michal Stanak
wiley   +1 more source

Econometric Models of Forecasting Money Supply in India

open access: yes
Monetary policy is a very important factor influencing the working of the financial sector of the economy. Forecasting money supply is a part and parcel of designing monetary policy.
Das, Rituparna
core  

Food prices and food crises since 2020: evidence from Mali, northeast Nigeria, Sudan, and northern Uganda. [PDF]

open access: yesDisasters
Wiggins S   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy